Bandaram Pharma Packtech Intrinsic Value
BANDARAM Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹8.70 | ₹6.96 - ₹10.44 | -70.0% | EPS: ₹0.12, Sector P/E: 12x |
| Book Value Method | asset | ₹13.33 | ₹12.00 - ₹14.66 | -54.0% | Book Value/Share: ₹13.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹37.33 | ₹33.60 - ₹41.06 | +28.7% | Revenue/Share: ₹46.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹20.00 | ₹18.00 - ₹22.00 | -31.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹8.70 | ₹7.83 - ₹9.57 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹8.70 | ₹7.83 - ₹9.57 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹8.70 | ₹7.83 - ₹9.57 | -70.0% | EPS: ₹0.12, BVPS: ₹13.33 |
Want to compare with current market value? Check BANDARAM share price latest .
Valuation Comparison Chart
BANDARAM Intrinsic Value Analysis
What is the intrinsic value of BANDARAM?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Bandaram Pharma Packtech (BANDARAM) is ₹8.70 (median value). With the current market price of ₹29.00, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹8.70 to ₹37.33, indicating ₹8.70 - ₹37.33.
Is BANDARAM undervalued or overvalued?
Based on our multi-method analysis, Bandaram Pharma Packtech (BANDARAM) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.44 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.44x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Bandaram Pharma Packtech
Additional stock information and data for BANDARAM
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-4 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-1 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |